Skip to main content
LigaChem Biosciences Inc. logo

LigaChem Biosciences Inc. — Investor Relations & Filings

Ticker · 141080 ISIN · KR7141080002 KO Professional, scientific and technical activities
Open in API
Filings indexed 295 across all filing types
Latest filing 2021-11-17 M&A Activity
Country KR South Korea
Listing KO 141080

About LigaChem Biosciences Inc.

https://ligachembio.com/

LigaChem Biosciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative medicines. Leveraging its core expertise in medicinal chemistry, the company focuses on developing Antibody-Drug Conjugates (ADCs), immuno-oncology drugs, and small molecules. A key asset is its proprietary, next-generation ADC platform technology, engineered to overcome the limitations of conventional ADC technologies. The company's pipeline includes multiple programs targeting oncology, as well as other therapeutic areas such as antibiotics and anti-fibrotics. LigaChem Biosciences actively pursues global drug development through strategic partnerships, including co-development and licensing agreements with international pharmaceutical companies.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(ADC원천기술 이전계약 체결)
M&A Activity Classification · 100% confidence The document is a regulatory filing from LegoChem Biosciences regarding a major business event, specifically the signing of a technology licensing agreement (ADC platform). It details the contract terms, financial milestones, and counterparty information. This type of disclosure is a standard regulatory announcement for material corporate events in the Korean market, fitting the 'Regulatory Filings' category as it does not represent a periodic financial report, a dividend announcement, or a management change.
2021-11-17 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for LegoChem Biosciences, covering the period from January 1, 2021, to September 30, 2021. It contains detailed corporate information, capital changes, and financial structure data, which is characteristic of an interim/quarterly financial report. It is not an announcement of a report (RPA) or a simple regulatory filing (RNS) because it contains substantive financial and operational data. 9M 2021
2021-11-15 Korean
수시공시의무관련사항(공정공시)(Antengene과의 ADC 공동연구 및 기술이전옵션 계약체결)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure (Fair Disclosure) from LegoChem Biosciences regarding a new joint research and technology transfer option agreement with Antengene. It details the nature of the contract, financial terms, and the parties involved. Since it is a specific announcement of a business development/partnership agreement that does not fit into categories like M&A (which usually implies full mergers or acquisitions) or other specific financial reports, it falls under the general regulatory filing category.
2021-10-21 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service (국민연금공단) regarding their stake in LegoChem Biosciences. This type of filing is a regulatory requirement when an entity's shareholding crosses a specific threshold (in this case, 5%). According to the provided definitions, notifications of changes in significant share ownership levels are classified as 'Major Shareholding Notification'.
2021-10-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This document details the share ownership and changes in holdings by a company executive (Young Lag Cho of LegoChem Biosciences). In the context of financial filings, reports detailing personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2021-09-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required when an individual or entity acquires a significant stake (typically 5% or more) in a publicly traded company. The text contains detailed tables of shareholding changes, transaction dates, and the identity of the major shareholder (조긍수). This falls under the 'Major Shareholding Notification' category.
2021-09-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.